New drug trial aims to slow kidney damage in rare lowe syndrome
Disease control
Not yet recruiting
This early study tests a drug called piclidenoson in 5 adult men with Lowe syndrome, a rare genetic disorder that harms the kidneys. The goal is to see if the drug can improve how the kidneys reabsorb important small proteins over 6 months. Researchers will also check safety and …
Phase: PHASE2 • Sponsor: Can-Fite BioPharma • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC